Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 7: 40687, 2017 01 13.
Article in English | MEDLINE | ID: mdl-28084430

ABSTRACT

In the present study, channelrhodopsin 2 (ChR2) was specifically introduced into murine cells expressing the Phenylethanolamine n-methyltransferase (Pnmt) gene, which encodes for the enzyme responsible for conversion of noradrenaline to adrenaline. The new murine model enabled the identification of a distinctive class of Pnmt-expressing neuroendocrine cells and their descendants (i.e. Pnmt+ cell derived cells) within the heart. Here, we show that Pnmt+ cells predominantly localized to the left side of the adult heart. Remarkably, many of the Pnmt+ cells in the left atrium and ventricle appeared to be working cardiomyocytes based on their morphological appearance and functional properties. These Pnmt+ cell derived cardiomyocytes (PdCMs) are similar to conventional myocytes in morphological, electrical and contractile properties. By stimulating PdCMs selectively with blue light, we were able to control cardiac rhythm in the whole heart, isolated tissue preparations and single cardiomyocytes. Our new murine model effectively demonstrates functional dissection of cardiomyocyte subpopulations using optogenetics, and opens new frontiers of exploration into their physiological roles in normal heart function as well as their potential application for selective cardiac repair and regeneration strategies.


Subject(s)
Heart Rate , Myocardium/cytology , Myocytes, Cardiac/physiology , Optogenetics , Phenylethanolamine N-Methyltransferase/genetics , Animals , Calcium Signaling , Electrophysiological Phenomena , Fluorescent Antibody Technique , Gene Expression , Genes, Reporter , Immunohistochemistry , Mice , Mice, Transgenic , Optogenetics/methods , Phenylethanolamine N-Methyltransferase/metabolism
2.
J Neurosci ; 34(44): 14739-51, 2014 Oct 29.
Article in English | MEDLINE | ID: mdl-25355226

ABSTRACT

Painful experiences are multilayered, composed of sensory, affective, cognitive and behavioral facets. Whereas it is well accepted that the development of chronic pain is due to maladaptive neuronal changes, the underlying molecular mechanisms, their relationship to the different pain modalities, and indeed the localization of these changes are still unknown. Brain-derived neurotrophic factor (BDNF) is an activity-dependent neuromodulator in the adult brain, which enhances neuronal excitability. In the spinal cord, BDNF underlies the development and maintenance of inflammatory and neuropathic pain. Here, we hypothesized that BDNF could be a trigger of some of these plastic changes. Our results demonstrate that BDNF is upregulated in the anterior cingulate cortex (ACC) and the primary sensory cortex (S1) in rats with inflammatory pain. Injections of recombinant BDNF (into the ACC) or a viral vector synthesizing BDNF (into the ACC or S1) triggered both neuronal hyperexcitability, as shown by elevated long-term potentiation, and sustained pain hypersensitivity. Finally, pharmacological blockade of BDNF-tropomyosin receptor kinase B (TrkB) signaling in the ACC, through local injection of cyclotraxin-B (a novel, highly potent, and selective TrkB antagonist) prevented neuronal hyperexcitability, the emergence of cold hypersensitivity, and passive avoidance behavior. These findings show that BDNF-dependent neuronal plasticity in the ACC, a structure known to be involved in the affective-emotional aspect of pain, is a key mechanism in the development and maintenance of the emotional aspect of chronic pain.


Subject(s)
Affect/physiology , Brain-Derived Neurotrophic Factor/metabolism , Gyrus Cinguli/metabolism , Hyperalgesia/metabolism , Neuronal Plasticity/physiology , Somatosensory Cortex/metabolism , Affect/drug effects , Animals , Behavior, Animal/drug effects , Behavior, Animal/physiology , Brain-Derived Neurotrophic Factor/genetics , Brain-Derived Neurotrophic Factor/pharmacology , Gyrus Cinguli/drug effects , Gyrus Cinguli/physiopathology , Hyperalgesia/chemically induced , Hyperalgesia/physiopathology , Inflammation/chemically induced , Inflammation/metabolism , Inflammation/physiopathology , Male , Neuronal Plasticity/drug effects , Peptides, Cyclic/pharmacology , Rats , Rats, Sprague-Dawley , Receptor, trkB/antagonists & inhibitors , Somatosensory Cortex/drug effects , Somatosensory Cortex/physiopathology , Up-Regulation/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...